Stevanato Group (NYSE:STVN) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Stevanato Group (NYSE:STVN) posted its earnings results on Friday. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01), Briefing.com reports. The firm had revenue of €273.57 million for the quarter. Stevanato Group had a return on equity of 10.44% and a net margin of 11.83%.The business’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.10 EPS.

Stevanato Group Price Performance

STVN stock traded up €0.20 during trading on Friday, hitting €18.23. The stock had a trading volume of 655,785 shares, compared to its average volume of 671,758. The stock has a market cap of $5.52 billion, a price-to-earnings ratio of 31.43, a price-to-earnings-growth ratio of 1.70 and a beta of 0.75. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. The company’s 50 day moving average price is €15.16 and its two-hundred day moving average price is €18.75. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00.

Stevanato Group News Summary

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Stevanato posted first-quarter 2026 revenue of €273.6 million, up 7% year over year and 10% at constant currency, driven by high-value solutions growth. Article Title
• Positive Sentiment: The company’s Q1 earnings came in at about €0.11–€0.13 per share, with one report noting a beat versus the €0.12 consensus, helping support the stock’s rebound. Article Title
• Positive Sentiment: Stevanato maintained its 2026 revenue guidance of €1.260 billion to €1.290 billion, signaling confidence in demand and execution despite macro uncertainty. Article Title
• Positive Sentiment: Management highlighted progress toward RTU cartridge production beginning in early 2027, which could expand the company’s addressable market and support longer-term growth. Article Title
• Neutral Sentiment: The company also filed a Form 6-K and held its Q1 earnings call, which mainly provided additional detail on the quarterly update rather than new material surprises. Article Title
• Neutral Sentiment: Coverage on valuation after the recent share-price rebound suggests investors are now weighing whether the stock’s recovery has already priced in some of the near-term earnings improvement. Article Title

Analysts Set New Price Targets

Several research analysts have recently issued reports on STVN shares. Weiss Ratings downgraded Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 11th. Wall Street Zen cut shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Citigroup cut their target price on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. KeyCorp reduced their price target on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Finally, Morgan Stanley lowered their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, March 6th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors have recently modified their holdings of the company. Quantessence Capital LLC purchased a new stake in Stevanato Group in the 3rd quarter worth approximately $526,000. Graham Capital Management L.P. purchased a new position in shares of Stevanato Group during the 4th quarter worth $351,000. Vident Advisory LLC acquired a new stake in shares of Stevanato Group during the third quarter worth $303,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Stevanato Group during the fourth quarter worth $287,000. Finally, Captrust Financial Advisors grew its position in shares of Stevanato Group by 78.2% in the fourth quarter. Captrust Financial Advisors now owns 13,925 shares of the company’s stock valued at $280,000 after purchasing an additional 6,110 shares during the period.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.